The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8691753, 29 ID: ALA3670714
Chembl Id: CHEMBL3670714
PubChem CID: 50991967
Max Phase: Preclinical
Molecular Formula: C26H31N3O8
Molecular Weight: 513.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1ccc(COc2ccccc2)cc1
Standard InChI: InChI=1S/C26H31N3O8/c27-25(35)20(11-14-23(31)32)29-26(36)21(12-15-24(33)34)28-22(30)13-10-17-6-8-18(9-7-17)16-37-19-4-2-1-3-5-19/h1-9,20-21H,10-16H2,(H2,27,35)(H,28,30)(H,29,36)(H,31,32)(H,33,34)/t20-,21-/m0/s1
Standard InChI Key: RAOGWYCOADLHPD-SFTDATJTSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.55Molecular Weight (Monoisotopic): 513.2111AlogP: 1.38#Rotatable Bonds: 16Polar Surface Area: 185.12Molecular Species: ACIDHBA: 6HBD: 5#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.83CX Basic pKa: CX LogP: 1.04CX LogD: -5.12Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.22Np Likeness Score: -0.20
References 1. (2014) Pseudodipeptides as MMP inhibitors,